Machine learning to combat hospital-acquired infections

March 13, 2018, Skolkovo Institute of Science and Technology

A group of scientists and doctors led by Skoltech Professor Vladimir Zelman has studied hospital-acquired meningitis risk factors using machine learning methods. Their research findings were published in the Journal of Critical Care.

Hospital-acquired meningitis is a grave complication that develops as a result of neurosurgical interventions and brain injuries, and often leads to disability and death. The disease is extremely difficult to treat, since in the majority of cases, it is caused by bacteria resistant to multiple antibiotics. Studying the main risk factors and finding ways of preventing infection are the main tools for reducing the incidence of hospital-acquired meningitis.

From 2010 to 2017, scientists from Skoltech and the University of Southern California jointly with doctors from the N.N. Burdenko Center for Neurosurgery studied a group of 2,286 patients undergoing intensive treatment for nervous system diseases and injuries. Of these, 216 were diagnosed with hospital-acquired meningitis. To identify meningitis risk factors, the researchers used several mathematical approaches, including classical statistical analysis and machine learning. They discovered four key risk factors: craniotomy, infection in the area operated on, leakage of the fluid circulating in the brain, and drainage of the brain ventricles. Machine learning provided convincing testimony to the strong impact of these four factors on the disease pathway.

This is the first study to unveil the truth about hospital-acquired meningitis morbidity in Russia and to demonstrate the efficiency of machine learning in the prediction of . "Our project addresses a unique and vast collection of clinical observations. This is an absolutely unprecedented experience for Russia. The novelty of the data collection and analysis approach provides good grounds for arguing that this study is a big step forward in the search for effective methods of fighting hospital-acquired meningitis. The main challenge we are faced with is preventing bacteria from spreading over the hospital and getting into a patient's nervous system. Of course, there is still a lot of work ahead but I believe that this project is an excellent example of successful international cooperation that should be continued," says Project Lead and Skoltech Professor Vladimir Zelman.

Explore further: Study finds only half of infants with deadly meningitis show traditional signs of the disease

More information: Savin, Ivan, Ksenia Ershova, Nataliya Kurdyumova, Olga Ershova, Oleg Khomenko, Gleb Danilov, Michael Shifrin, and Vladimir Zelman. "Healthcare-Associated Ventriculitis and Meningitis in a Neuro-ICU: Incidence and Risk Factors Selected by Machine Learning Approach." Journal of Critical Care 45 (June 1, 2018): 95–104. doi.org/10.1016/j.jcrc.2018.01.022

Related Stories

Study finds only half of infants with deadly meningitis show traditional signs of the disease

February 26, 2018
Researchers at St George's, University of London, say their new study shows the classic symptoms associated with bacterial meningitis are uncommon in young infants less than three months of age – the group at highest risk ...

Infectious diseases A-Z: identifying meningitis

January 16, 2017
It's the height of flu season but not all symptoms of the flu virus point to influenza. Sudden fever and headache also may be symptoms of early meningitis, which often mimics the flu.

Non-ventilator hospital-acquired pneumonia risk affects all ages

January 13, 2018
(HealthDay)—Non-ventilator hospital-acquired pneumonia (NV-HAP) is a significant burden in U.S. acute care hospitals and poses a risk to nonelderly, non-intensive unit (ICU) patients, according to research published in ...

Poor treatment of meningitis in kids can lead to tragedies warn experts

August 24, 2017
Research has shown that bacterial meningitis in infants may not be being diagnosed or acted on quickly enough by medical professionals.

Scientists develop new mouse model to study Salmonella meningitis

December 9, 2016
National Institutes of Health (NIH) scientists have established in mice a way to study potentially life-threatening meningitis caused by Salmonella. Bacterial meningitis happens when bacteria infect the central nervous system ...

Analysing meningitis genes to identify new treatments

April 19, 2013
Scientists at the University of Liverpool are working to identify genes involved in the development of bacterial meningitis to support the search for new vaccine candidates.

Recommended for you

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

New evidence of a preventative therapy for gout

September 17, 2018
Among patients with cardiovascular disease, it's a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular ...

"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018
An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists ...

Flu shot rates in clinics drop as day progresses, but nudges help give them a boost

September 14, 2018
Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network. However, "nudging" clinical staff ...

Rare antibodies show scientists how to neutralize the many types of Ebola

September 13, 2018
Two new studies by scientists at Scripps Research are bringing Ebola virus's weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.